Works matching IS 1021335X AND DT 2024 AND VI 51 AND IP 1

Results: 17

Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8676

By:

Nanamiya, Tomoyuki;
Takane, Kiyoko;
Yamaguchi, Kiyoshi;
Okawara, Yuya;
Arakawa, Mariko;
Saku, Akari;
Ikenoue, Tsuneo;
Fujiyuki, Tomoko;
Yoneda, Misako;
Kai, Chieko;
Furukawa, Yoichi

Publication type:

Article

The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review).

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8675

By:

Cheng, Zhinan;
Cui, Hongwei;
Wang, Yaqi;
Yang, Jin;
Lin, Chunyang;
Shi, Xiaoyu;
Zou, Yuxiu;
Chen, Jing;
Jia, Xiaoqiong;
Su, Liqing

Publication type:

Article

Oncogenic role of FOXM1 in human prostate cancer (Review).

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8674

By:

Lee, Da Young;
Chun, Jung Nyeo;
So, Insuk;
Jeon, Ju-Hong

Publication type:

Article

SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8673

By:

Ye, Gongjie;
Tu, Linglan;
Li, Zhuduo;
Li, Xiangyu;
Zheng, Xiaoliang;
Song, Yongfei

Publication type:

Article

[Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR‑181a‑5p/ROCK2 axis.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8672

By:

Chi, Junlin;
Liu, Shuang;
Wu, Zhizhong;
Shi, Yanqiang;
Shi, Chengmin;
Zhang, Tong;
Xiong, Binghong;
Zeng, Yujian;
Dong, Xiangqian

Publication type:

Article

Celastrol enhances TRAIL‑R2‑mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase‑dependent manner.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8671

By:

Bao, Yuhang;
Wu, Xiuxian;
Kanematsu, Akihiro;
Kita, Yuki;
Kobayashi, Takashi;
Kakehi, Yoshiyuki;
Yamamoto, Shingo

Publication type:

Article

RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8670

By:

Lu, Macheng;
Hu, Xingqian;
Cheng, Cong;
Zhang, Yuan;
Huang, Longchang;
Kong, Xiangpeng;
Li, Zengyao;
Zhang, Qiuhua;
Zhang, Ye

Publication type:

Article

[Rectacted] miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8669

By:

Chen, Xu-E;
Chen, Pu;
Chen, Shan-Shan;
Ma, Ting;
Shi, Guang;
Zhou, Ya;
Li, Ji;
Sheng, Liang

Publication type:

Article

β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8668

By:

Kim, Yerin;
Oh, Yeonsoo;
Kim, Yoo Sun;
Shin, Jae-Ho;
Lee, Yeon Su;
Kim, Yuri

Publication type:

Article

Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review).

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8667

By:

Ren, Jing;
Kong, Pengzhou;
Wang, Yanqiang;
Guo, Dawei;
Zhang, Ling

Publication type:

Article

Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8666

By:

He, Ji;
Bugde, Piyush;
Li, Jiawei;
Biswas, Riya;
Li, Siting;
Yang, Xuewei;
Tian, Fang;
Wu, Zimei;
Li, Yan

Publication type:

Article

Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8665

By:

Song, Wei;
Li, Zhuo;
Xia, Ming;
Xiao, Wei

Publication type:

Article

U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8664

By:

Nian, Qing;
Li, Yihui;
Li, Jingwei;
Zhao, Liyun;
Rodrigues Lima, Fernando;
Zeng, Jinhao;
Liu, Rongxing;
Ye, Zhijun

Publication type:

Article

[Retracted] miR‑216b inhibits glioma cell migration and invasion through suppression of FoxM1.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8663

By:

Zhang, Tingting;
Ma, Guangtao;
Zhang, Yan;
Huo, Hongda;
Zhao, Yuqian

Publication type:

Article

Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8662

By:

Urban, Lukáš;
Novák, Štepán;
Čoma, Matúš;
Dvořánková, Barbora;
Lacina, Lukáš;
Šáchová, Jana;
Hradilová, Miluše;
Svatoňová, Petra;
Kolář, Michal;
Strnad, Hynek;
Březinová, Jana;
Smetana Jr, Karel;
Gál, Peter;
Szabo, Pavol

Publication type:

Article

MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8661

By:

Choi, Sujin;
An, Hyun-Ju;
Yeo, Hyun Jeong;
Sung, Min-Ji;
Oh, Jisu;
Lee, Kwanbum;
Lee, Seung Ah;
Kim, Seung Ki;
Kim, Junhan;
Kim, Isaac;
Lee, Soonchul

Publication type:

Article

[Retracted] microRNA‑196b promotes cell migration and invasion by targeting FOXP2 in hepatocellular carcinoma.

Published in:

Oncology Reports, 2024, v. 51, n. 1, p. N.PAG, doi. 10.3892/or.2023.8660

By:

Yu, Zhaoxiang;
Lin, Xiaobo;
Tian, Ming;
Chang, Weiping

Publication type:

Article